Coloplast CEO wants to increase US market share to global level

The company aims to grow in the US through new agreements with procurement firms.

Kristian Villumsen, CEO at Coloplast | Photo: Stine Bidstrup/Ritzau Scanpix

After securing agreements with US procurement companies Vizient and Premier, which give manufacturers easier access to hospitals, Coloplast is aiming to acquire market shares in the country equivalent to its global presence – equating to around 40-55 percent of the market, Danish financial daily Børsen reports.

"I tend to say to my US organization that we can't have any other ambition than to match global market shares. We haven't done that yet," says Kristian Villumsen, CEO at Coloplast, to the media.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs